The News Journal (Delaware Online)
Liz S. in Delaware is concerned that the Most Favored Nation policy can negatively impact both access to medicines currently, and “weaken the financial foundation for developing new treatments” in the future. “For patients hoping for the next breakthrough, whether for cancer, heart disease, or a rare illness, that is not a small risk.”